SI
SGYP

Stephens Inc’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Stephens Inc’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-28,500
Closed -$127K – 918
2017
Q2 		$127K Buy
28,500
+8,000
+39% +$33K ﹤0.01% 817
2017
Q1 		$96K Buy
20,500
+300
+1% +$1.74K ﹤0.01% 801
2016
Q4 		$123K Buy
20,200
+8,200
+68% +$42.9K 0.01% 741
2016
Q3 		$66K Buy
+12,000
New +$56.2K ﹤0.01% 743
2014
Q4 		– Sell
-14,500
Closed -$40K – 861
2014
Q3 		$40K Sell
14,500
-500
-3% -$1.81K ﹤0.01% 781
2014
Q2 		$61K Buy
+15,000
New +$63.7K ﹤0.01% 803

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return